HomeConditionsTreatmentsTrials
  1. /
  2. treatments
    /

Sintilimab 200 mg, intravenously (IV) every 3 weeks(Q3W)

📊

Treatment Reviews

See user reviews and ratings for Sintilimab 200 mg, intravenously (IV) every 3 weeks(Q3W)

🔬

Mega-Study

See real-world data analysis for Sintilimab 200 mg, intravenously (IV) every 3 weeks(Q3W)

📚

Meta-Analysis

See a meta-analysis of all available research

🔍

Clinical Trials

See clinical trials related to Sintilimab 200 mg, intravenously (IV) every 3 weeks(Q3W)

Contact: hello@crowdsourcingcures.org

Privacy Policy